AstraZeneca launches its new diabetes drug Onglyza
The world’s seventh-largest pharma company, AstraZeneca Pharma and biopharmaceutical firm Bristol-Myers Squibb have launched their 9-month-old diabetes drug Onglyza in India – the biggest market for the drug.
April 30, 2010 | Filed Under Diabetes
Comments
Leave a Reply
You must be logged in to post a comment.